Among the 3,532 participants in the FLOW trial, 19.2% (678 individuals) had heart failure at baseline, with 47.9% classified as having HFpEF, 18.1% as having heart failure with reduced ejection fraction (HFrEF), and 33.9% with unknown status
In addition, this article will provide tips for managing acid reflux while taking semaglutide and explain when to see a doctor if symptoms become severe
Laboratory studies and in vitro testing have demonstrated that BPC-157 peptide could hold the following benefits: Research on BPC-157 peptide, also known as the body protection compound, has revealed promising findings across various fields
The committee concluded that there is not enough evidence to show the drugs directly cause these symptoms, but noted the complex interplay between mental illness and chronic endocrine disorders, as per The Guardian
It is always advisable to check with a healthcare professional before starting any new supplement